Capricor Therapeutics
CAPR
CAPR
18 hedge funds and large institutions have $630K invested in Capricor Therapeutics in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
79% less capital invested
Capital invested by funds: $3.01M → $630K (-$2.38M)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$279K | |
| 2 | +$73.2K | |
| 3 | +$32K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.3K |
| 5 |
JP Morgan Chase
New York
|
+$3.66K |
Top Sellers
| 1 | -$390K | |
| 2 | -$209K | |
| 3 | -$51K | |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$44.5K |
| 5 |
Goldman Sachs
New York
|
-$31K |